950130 엑세스바이오
기본 정보
- 섹터: KOSDAQ
- 시가총액: 805억원 (2026-06-30 기준)
- 첫 등장: — (마커 미등장)
- 태그: 매크로/바이오헬스 · 체외진단 · 진단키트 · 면역진단 · 분자진단
- 네이버 금융: 🔗
기업개요
- 동사는 2002년 설립되어 2013년 코스닥 상장한 체외진단 전문기업으로, 6개 비상장 종속회사를 보유하고 있음.
- 면역화학진단, 바이오센서, 분자진단 기술로 말라리아, G6PD, 독감, 코로나 바이러스 등의 신속진단시약을 개발·제조·판매하며, POCT 및 IVD 시장에서 사업을 하고 있음.
- 2026년 의약품 유통 영업권 양수해 비만·체중관리, 대사·혈당 조절, 위장관계 의약품 등 유통사업으로 확장하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-14 | 2,265 | 2,195 | 🔵 -3.09% | — | ×0.8 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-13 | 2,500 | 2,265 | 🔵 -9.40% | — | ×2.0 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.2 | +0.0 |
| 2026-07-10 | 2,320 | 2,500 | 🔴 +7.76% | — | ×0.9 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | +0.0 | -0.3 | +0.0 |
| 2026-07-09 | 2,415 | 2,320 | 🔵 -3.93% | — | ×0.5 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-08 | 2,360 | 2,415 | 🔴 +2.33% | — | ×1.1 | ⚫ 그외 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.2 | +0.1 |
| 2026-07-07 | 2,370 | 2,360 | 🔵 -0.42% | — | ×0.4 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-06 | 2,220 | 2,370 | 🔴 +6.76% | — | ×0.8 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-03 | 2,195 | 2,220 | 🔴 +1.14% | — | ×0.4 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | +0.0 | -0.2 | -0.0 |
| 2026-07-02 | 2,230 | 2,195 | 🔵 -1.57% | — | ×0.6 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-01 | 2,290 | 2,230 | 🔵 -2.62% | — | ×0.4 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-06-30 | 2,305 | 2,290 | 🔵 -0.65% | — | ×0.3 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-06-29 | 2,190 | 2,305 | 🔴 +5.25% | — | ×0.5 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | +0.0 | -0.3 | +0.0 |
| 2026-06-26 | 2,255 | 2,190 | 🔵 -2.88% | — | ×1.0 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | +0.0 | +0.0 | -0.8 | +0.1 |
| 2026-06-25 | 2,305 | 2,255 | 🔵 -2.17% | — | ×0.4 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-06-24 | 2,295 | 2,305 | 🔴 +0.44% | — | ×0.9 | 🟢 외인 | +0.9억 | +0.9 | +0.0 | +0.0 | +0.0 | -0.9 | +0.0 |
| 2026-06-23 | 2,445 | 2,295 | 🔵 -6.13% | — | ×1.1 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | -0.3 | +0.0 | |
| 2026-06-22 | 2,515 | 2,445 | 🔵 -2.78% | — | ×0.5 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | -0.1 | -0.1 | |
| 2026-06-19 | 2,730 | 2,515 | 🔵 -7.88% | — | ×0.8 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.3 | -0.2 | |
| 2026-06-18 | 2,780 | 2,730 | 🔵 -1.80% | — | ×0.5 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.2 | -0.0 | |
| 2026-06-17 | 2,670 | 2,780 | 🔴 +4.12% | — | ×0.8 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-06-16 | 2,640 | 2,670 | 🔴 +1.14% | — | ×0.5 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | +0.0 | +0.6 | +0.0 | |
| 2026-06-15 | 2,555 | 2,640 | 🔴 +3.33% | — | ×0.7 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | +0.0 | +1.0 | -0.1 | |
| 2026-06-12 | 2,565 | 2,555 | 🔵 -0.39% | — | ×0.6 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | +0.0 | +0.5 | +0.0 | |
| 2026-06-11 | 2,595 | 2,565 | 🔵 -1.16% | — | ×0.4 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | +0.0 | +0.6 | +0.0 | |
| 2026-06-10 | 2,580 | 2,595 | 🔴 +0.58% | — | ×0.5 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | +0.0 | |
| 2026-06-09 | 2,565 | 2,580 | 🔴 +0.58% | — | ×0.5 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-06-08 | 2,715 | 2,565 | 🔵 -5.52% | — | ×0.6 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | -0.3 | -0.0 | |
| 2026-06-05 | 2,805 | 2,715 | 🔵 -3.21% | — | ×0.1 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | +0.0 | +0.4 | +0.1 | |
| 2026-06-04 | 2,725 | 2,805 | 🔴 +2.94% | — | ×0.1 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | -0.0 | +0.6 | +0.0 | |
| 2026-06-02 | 2,805 | 2,725 | 🔵 -2.85% | — | ×0.2 | 🟢 외인 | +1.1억 | +1.1 | +0.0 | +0.0 | -1.1 | -0.0 | |
| 2026-06-01 | 3,050 | 2,805 | 🔵 -8.03% | — | ×0.2 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-05-29 | 3,040 | 3,050 | 🔴 +0.33% | — | ×0.1 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-05-28 | 3,220 | 3,040 | 🔵 -5.59% | — | ×0.1 | 🟢 외인 | +0.8억 | +0.8 | +0.0 | -0.0 | -0.9 | +0.2 | |
| 2026-05-27 | 3,460 | 3,220 | 🔵 -6.94% | — | ×0.3 | ⚫ 그외 | -0.9억 | -0.9 | +0.0 | +0.0 | +0.3 | +0.7 | |
| 2026-05-26 | 3,460 | 3,460 | ⚪ +0.00% | — | ×0.3 | 🔻 개인 | -2.2억 | -2.2 | +0.0 | +0.0 | +2.5 | -0.3 | |
| 2026-05-22 | 3,390 | 3,460 | 🔴 +2.06% | — | ×0.2 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | +0.0 | -0.7 | +0.2 |
일자별 사유 (최신 위)
2026-07-10
- 사유: —
- 섹터 컨텍스트: 기타 (smart +0.0억)
- 매크로 원인: 공통 촉매보다 신약개발·특허·제휴 등 종목별 개별 바이오 재료가 각각 부각됨 (보통)